Frederick M. Schnell
Frederick M. Schnell publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Economics and Econometrics, on topics such as Cancer Treatment and Pharmacology, Colorectal Cancer Treatments and Studies and Lung Cancer Research Studies.
- World rank
- #2,803,140 of 7,710,434 ranked researchers
- Rank in United States
- #813,238 of 1,627,098
- Works
- 31
- Citations
- 788
- Citations per work
- 25.4
What does Frederick M. Schnell research?
Frederick M. Schnell's work is mostly in Medicine (58%), Economics, Econometrics and Finance (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1857.8%
- Medicine1857.8%
- Everything else1136.2%
- Social Sciences26.0%
- 1Oncology26% of their works
- 2Pulmonary and Respiratory Medicine14% of their works
- 3Economics and Econometrics6% of their works
- 4Cardiology and Cardiovascular Medicine6% of their works
- 5Surgery6% of their works
- 6Public Health, Environmental and Occupational Health5% of their works
Research topics
Which keywords describe Frederick M. Schnell's research?
The keywords of their largest research topics: Chemotherapy, Biomarkers, Immunotherapy, Quality of Life, Prognostic Factors, Cetuximab, Chemotherapy-Induced Peripheral Neuropathy and KRAS Mutations.
- International Myeloma Working Group
- Endometrial Carcinoma
- Chronic Lymphocytic Leukemia
- Cancer Survivorship
- Prostate Cancer
- Androgen Receptor
- KRAS Mutations
- Cetuximab
- Quality of Life
- Biomarkers
- Chemotherapy
- Immunotherapy
- Prognostic Factors
- Chemotherapy-Induced Peripheral Neuropathy
- Taxanes
- Genomic Profiles
- Small-Cell Lung Cancer
- Cervical Cancer
- Diagnosis Criteria
- Genomic Aberrations
- Patient-Reported Outcomes
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Chemotherapy72 topics
- Biomarkers62 topics
- Immunotherapy62 topics
- Quality of Life62 topics
- Prognostic Factors52 topics
- Cetuximab41 topic
- Chemotherapy-Induced Peripheral Neuropathy41 topic
- KRAS Mutations41 topic
- Taxanes41 topic
- Androgen Receptor31 topic
- Genomic Profiles31 topic
- Prostate Cancer31 topic
- Small-Cell Lung Cancer31 topic
- Cancer Survivorship21 topic
- Cervical Cancer21 topic
- Chronic Lymphocytic Leukemia21 topic
- Diagnosis Criteria21 topic
- Endometrial Carcinoma21 topic
- Genomic Aberrations21 topic
- International Myeloma Working Group21 topic
- Patient-Reported Outcomes21 topic
Where does Frederick M. Schnell work?
Frederick M. Schnell's main affiliation in the publication record is Navicent Health, United States.
How many publications and citations does Frederick M. Schnell have?
OpenAlex counts 31 works and 788 citations for Frederick M. Schnell, an h-index of 10, ranking #2,803,140 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Frederick M. Schnell. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.